A Phase I/II Trial of RAD001/Capecitabine in Refractory Gastric Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 01 Feb 2016
At a glance
- Drugs Capecitabine (Primary) ; Everolimus (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 07 Sep 2013 Status changed from recruiting to completed according to results published in the Investigational New Drugs.
- 11 Jan 2012 Planned end date changed from 1 Dec 2011 to 1 Apr 2012 as reported by ClinicalTrials.gov.
- 09 Apr 2010 New trial record